Search Results 521-530 of 19174 for creatinine

1. A Study of Paclitaxel with or without Cixutumumab as Second-Line Therapy for Treating Patients with Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer - Mayo Clinic

   Creatinine ≤ 1.5 X institutional ULN or creatinine clearance ≥ 60 mL/min/1.73m^2 for patients with creatinine levels above institutional normal; Must have ...

2. A Study to Evaluate Hypoxia and Inflammatory Injury in Human Renovascular Hypertension - Mayo Clinic

   Creatinine < 2.2 mg/dL for Caucasian males, < 2.0 Caucasian females,< 2.4 African-American males, < 2.1 mg/dL African-American females. Hypertension ...

3. Olaparib or Cediranib Maleate and Olaparib Compared With Standard Platinum-Based Chemotherapy in Treating Patients With Recurrent Platinum-Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer - Mayo Clinic

   ... creatinine levels above institutional normal; Urine protein: creatinine ratio (UPC) of =< 1 or less than or equal to 2+ proteinuria on two consecutive ...

4. A Study to Test the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) with One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors - Mayo Clinic

   Creatinine ≤ 1.5 x upper limit of normal (ULN); OR; Creatinine clearance ≥ 40 mL/min/1.73 m2 (calculated using the CKD-EPI equation or Cockroft-Gault ...

5. A Study to Determine Serum and Urine Reference Ranges in Patients with Normal Renal Function Being Administered Gadobutrol for an Enhanced Magnetic Resonance Imaging (MRI) - Mayo Clinic

   Serum creatinine <1.4 mg/dL; or; Glomerular filtration rate; ≥60 mL/min. No gadolinium-enhanced MRI in last 6 months. Scheduled to undergo a gadobutrol ...

6. Vemurafenib and Cobimetinib in Treating Patients With BRAF V600E Mutation Positive Craniopharyngioma - Mayo Clinic

   Creatinine =< 1.5 mg/dL OR creatinine clearance >= 45mL/min; Bilirubin =< 1.5 upper limit of normal (ULN); Aspartate aminotransferase (AST)/alanine ...

7. LUPKYNIS US Registry Trial - Mayo Clinic

   serum creatinine and/or eGFR;; Have access to US healthcare insurance;; Ability to understand and provide written informed consent. Exclusion Criteria: Off ...

8. A Multicenter Phase I Study of MRX34, MicroRNA miR-RX34 Liposomal Injection - Mayo Clinic

   ... creatinine clearance ≥ 60 mL/min/1.73 m2 for patients with creatinine levels above 1.5 times the institutional normal; Acceptable hematological status ...

9. Phase II Trial of Irinotecan, Cetuximab, and Bevacizumab Compared With Irinotecan, Cetuximab, and Placebo in KRAS-Wildtype, Irinotecan-Refractory, Metastatic Colorectal Cancer - Mayo Clinic

   Creatinine within institutional limits of normal OR; creatinine clearance >60 mL/min/1.73 m2 for patients with creatinine levels above institutional normal.

10. Evaluation of Long Term Safety and Efficacy of Glepaglutide in Treatment of SBS - Mayo Clinic

    Systemic antibiotics or antibiotics affecting the gastrointestinal tract;; Oral rehydration fluids. Estimated creatinine clearance (CLcr; by the Cockcroft-Gault ...